Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co. KGaA    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Fresenius : REFILE-Fresenius specifies 2021 outlook amid COVID-19 uncertainty

02/23/2021 | 01:01am EST

Feb 23 (Reuters) - German healthcare group Fresenius narrowed down its 2021 sales growth forecast as it reported a slight full-year results beat on Tuesday, saying improvement in its businesses is heavily dependent on levels of vaccination coverage in its markets.

Fresenius said it expected 2021 sales to grow in a low to mid-single-digit percentage range and confirmed its forecast for at least broadly stable net income. In early February, the group said it expected "healthy sales growth."

The company added net income for the group excluding dialysis unit Fresenius Medical Care should grow in a mid-to high single digit percentage range in constant currency.

Fresenius' full-year net income came in at 1.80 billion euros ($2.19 billion) on a currency-adjusted basis, in line with the preliminary announcement that it would decline by as much as 4% and analysts' forecasts.

($1 = 0.8217 euros) ($1 = 0.8218 euros) (Reporting by Zuzanna Szymanska in Gdansk Editing by Tomasz Janowski)


© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
FRESENIUS MEDICAL CARE AG & CO. KGAA 0.76% 58.62 Delayed Quote.-14.69%
FRESENIUS SE & CO. KGAA 0.19% 35.99 Delayed Quote.-5.05%
All news about FRESENIUS SE & CO. KGAA
03/01DGAP-DD  : Fresenius Medical Care AG & Co. KGaA english
DJ
03/01FMC FRESENIUS MEDICAL CARE AG & CO K : Buy rating from Berenberg
MD
02/26PRESS RELEASE  : Nanogate SE: Divestment of Nanogate Kierspe GmbH
DJ
02/26FMC FRESENIUS MEDICAL CARE AG & CO K : Buy rating from Goldman Sachs
MD
02/26FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Neutral rating from JP Morgan
MD
02/26FRESENIUS SE  : JP Morgan gives a Buy rating
MD
02/25FRESENIUS SE & CO. KGAA : Release according to Article 40, Section 1 of the WpHG..
EQ
02/25FMC FRESENIUS MEDICAL CARE AG & CO K : Independant Research reiterates its Buy r..
MD
02/25DGAP-DD  : Fresenius SE & Co. KGaA english
DJ
02/25DGAP-DD  : Fresenius Medical Care AG & Co. KGaA english
DJ
More news
Financials
Sales 2020 36 158 M 43 409 M 43 409 M
Net income 2020 1 735 M 2 083 M 2 083 M
Net Debt 2020 23 519 M 28 236 M 28 236 M
P/E ratio 2020 11,4x
Yield 2020 2,24%
Capitalization 20 030 M 24 153 M 24 047 M
EV / Sales 2020 1,20x
EV / Sales 2021 1,13x
Nbr of Employees 309 114
Free-Float 72,0%
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 45,55 €
Last Close Price 35,93 €
Spread / Highest target 89,3%
Spread / Average Target 26,8%
Spread / Lowest Target -50,8%
EPS Revisions
Managers and Directors
NameTitle
Stephan Sturm President & Chief Executive Officer
Rachel Clare Empey Chief Financial Officer
Gerd Krick Chairman-Supervisory Board
Jürgen Götz Chief Legal & Compliance Officer
Niko Stumpfögger Deputy Chairman-Supervisory Board
Sector and Competitors